<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
-----
Safeguard Health Enterprises
----------------------------
(Name of Issuer)
Common Stock
------------
(Title of Class of Securities)
786444109000
------------
(CUSIP Number)
Mia Jensen, c/o The Burton Partnership, Limited Partnership
Post Office Box 4643 Jackson, Wyoming 83001
--------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
12/08/99
--------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of (S)(S)240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box. [_]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See (S)240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13D
CUSIP No. 786444109000 Page 2 of 7 Pages
- ----------------------- ---------------------
1 NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
The Burton Partnership, Limited Partnership
-------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS) (a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
OO
- --------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [_]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware Limited Partnership
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 521,300
-------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY -0-
-------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON -0-
-------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
521,300
- --------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.9%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
- --------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP No. 786444109000 Page 3 of 7 Pages
- ----------------------- ---------------------
1 NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
Donald W. Burton
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS) (a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
OO
- --------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [_]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 521,300
-------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY -0-
-------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON -0-
-------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
521,300
- --------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.9%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- --------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
- ------------------------------------ --------------------------------
| CUSIP No. 786444109000 | | Page 4 of 7 Pages |
| ------------------ | | ---- ----- |
- ------------------------------------ --------------------------------
Item 1. Security and Issuer
- ----------------------------
This statement relates to shares of Common Stock (the "Shares"), of Safeguard
Health Enterprises (the "Company"), having its principal executive offices at 95
Enterprise, Aliso Viejo, California.
Item 2. Identity and Background
- --------------------------------
This statement is being filed by The Burton Partnership, Limited Partnership
having its principal offices at P.O. Box 4643, Jackson, Wyoming 83001; and the
general partner of The Burton Partnership, Limited Partnership, Donald W.
Burton. The principal business of The Burton Partnership, Limited Partnership
is investment in public and private stocks. The general partner's principal
occupation is an investor.
The business address of the general partner is c/o The Burton Partnership,
Limited Partnership.
During the five years prior to the date hereof, neither The Burton
Partnership, Limited Partnership, nor its general partner has been convicted in
a criminal proceeding or has been a party to a civil proceeding ending in a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws.
The general partner is a United States citizen.
Item 3. Source and Amount of Funds or Other Consideration
- ----------------------------------------------------------
The Burton Partnership, Limited Partnership acquired a total of 521,300
shares of Safeguard Health Enterprises through open market transactions during a
period beginning February 16, 1999 and ending December 14, 1999 at prices
ranging from $.5625 to 3.00 per share, for an aggregate purchase price of
$917,031.
No part of the purchase price paid by The Burton Partnership, Limited
Partnership for shares was represented by funds or other consideration borrowed
or otherwise obtained for the purpose of acquiring, holding, trading or voting
shares of Safeguard Health Enterprises
Item 4. Purpose of the Transaction
- ------------------------------------
The Burton Partnership, Limited Partnership has purchased the Shares for
investment purposes only.
a. Depending on market conditions, its continuing evaluation of the business
and prospects of Safeguard Health Enterprises and other factors, The
Burton Partnership, Limited Partnership may buy or sell additional shares
in the open market. Neither The Burton Partnership, Limited Partnership,
nor the general partner has any present plans which relate to or would
result in:
b. An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving Safeguard Health Enterprises or any of
its subsidiaries;
c. A sale or transfer of a material amount of assets of Safeguard Health
Enterprises or any of its subsidiaries;
<PAGE>
SCHEDULE 13D
- ------------------------------------ --------------------------------
| CUSIP No. 786444109000 | | Page 5 of 7 Pages |
| ------------------ | | ---- ----- |
- ------------------------------------ --------------------------------
d. Any change in the present board of directors or management of the
issuer, including any plans or proposals to change the number of term of
directors or to fill any existing vacancies on the board;
e. Any material change in the present capitalization or dividend
policy of Safeguard Health Enterprises;
f. Any other material change in Safeguard Health Enterprises business or
corporate structure, including, but not limited to, if Safeguard Health
Enterprises is a closed-end investment company, any plans or proposals to make
any changes in its investment policy for which a vote is required by section 13
of the Investment Company Act of 1940;
g. Changes in Safeguard Health Enterprises's charter or bylaws or other
actions which may impede the acquisition of control of Safeguard Health
Enterprises by any person;
h. Causing a class of securities of Safeguard Health Enterprises to be
delisted from a national securities exchange or to cease to be authorized to be
quoted in an inter-dealer quotation system of a registered national securities
association;
i. A class of equity securities of Safeguard Health Enterprises becoming
eligible for termination of registration pursuant to Section 12(g)(4) of the
Securities Exchange Act of 1934; or
j. Any action similar to any of those enumerated above.
Item 5. Interest in Securities and The Issuer
- ----------------------------------------------
By virtue of his status as general partner of The Burton Partnership,
Limited Partnership, Donald W. Burton may thus be deemed to be beneficial owner
of the 521,300 shares which The Burton Partnership, Limited Partnership owns of
record, representing 10.9% of the Company. Donald W. Burton may thus be deemed
to share with The Burton Partnership, Limited Partnership the power to direct
the voting and disposition of the shares which The Burton Partnership, Limited
Partnership own of record.
The aggregate 521,300 shares purchased by The Burton Partnership, Limited
Partnership were obtained in the following open market transactions.
<TABLE>
<CAPTION>
(1) (2) (3) (4) (5)
Person who Settlement
Effected Date Number of Price Per Brokerage House & How
Transaction of Transaction Shares Share Transactions was Effected
- ------------------- --------------- ------------ -------------- ------------------------------
<S> <C> <C> <C> <C>
General Partner 02/22/99 10,000 2.8125 J. C. Bradford & Co.
General Partner 02/22/99 5,600 2.8125 J. C. Bradford & Co.
General Partner 02/22/99 5,100 2.8125 J. C. Bradford & Co.
General Partner 02/19/99 1,700 2.8125 J. C. Bradford & Co.
General Partner 02/19/99 1,100 2.7500 J. C. Bradford & Co.
General Partner 02/23/99 600 2.8125 J. C. Bradford & Co.
</TABLE>
<PAGE>
SCHEDULE 13D
- ------------------------------------ --------------------------------
| CUSIP No. 786444109000 | | Page 6 of 7 Pages |
| ------------------ | | ---- ----- |
- ------------------------------------ --------------------------------
<TABLE>
<S> <C> <C> <C> <C>
General Partner 02/24/99 9,300 2.8125 J. C. Bradford & Co.
General Partner 02/26/99 2,100 2.8125 J. C. Bradford & Co.
General Partner 02/16/99 1,600 2.7500 J. C. Bradford & Co.
General Partner 02/24/99 200 2.8125 J. C. Bradford & Co.
General Partner 03/03/99 2,000 2.8125 J. C. Bradford & Co.
General Partner 03/05/99 700 2.8125 J. C. Bradford & Co.
General Partner 03/08/99 10,000 2.8125 J. C. Bradford & Co.
General Partner 03/08/99 300 2.8125 J. C. Bradford & Co.
General Partner 03/09/99 5,000 2.8125 J. C. Bradford & Co.
General Partner 03/10/99 500 2.7500 J. C. Bradford & Co.
General Partner 03/10/99 5,000 2.8125 J. C. Bradford & Co.
General Partner 03/11/99 1,100 2.8125 J. C. Bradford & Co.
General Partner 03/12/99 300 2.8125 J. C. Bradford & Co.
General Partner 03/15/99 37,800 2.8125 J. C. Bradford & Co.
General Partner 03/22/99 300 2.8125 J. C. Bradford & Co.
General Partner 03/23/99 4,500 2.8125 J. C. Bradford & Co.
General Partner 03/24/99 3,000 2.8125 J. C. Bradford & Co.
General Partner 03/25/99 300 2.8125 J. C. Bradford & Co.
General Partner 03/26/99 17,900 2.8125 J. C. Bradford & Co.
General Partner 03/29/99 74,000 2.8125 J. C. Bradford & Co.
General Partner 03/29/99 30,000 2.7813 J. C. Bradford & Co.
General Partner 06/07/99 1,300 2.7500 J. C. Bradford & Co.
General Partner 06/08/99 1,800 2.7500 J. C. Bradford & Co.
General Partner 06/10/99 1,500 2.7500 J. C. Bradford & Co.
General Partner 06/11/99 3,100 2.7500 J. C. Bradford & Co.
General Partner 06/11/99 23,200 2.7500 J. C. Bradford & Co.
General Partner 06/16/99 100 2.7500 J. C. Bradford & Co.
General Partner 06/17/99 3,200 2.7500 J. C. Bradford & Co.
General Partner 06/29/99 1,000 3.0000 J. C. Bradford & Co.
General Partner 06/30/99 3,000 3.0000 J. C. Bradford & Co.
General Partner 07/02/99 3,100 3.0000 J. C. Bradford & Co.
General Partner 11/24/99 3,000 0.5625 J. C. Bradford & Co.
General Partner 11/24/99 3,000 0.5938 J. C. Bradford & Co.
General Partner 11/24/99 5,000 0.6200 J. C. Bradford & Co.
General Partner 11/24/99 5,000 0.6250 J. C. Bradford & Co.
General Partner 12/08/99 139,000 0.6250 J. C. Bradford & Co.
General Partner 12/09/99 75,000 0.6250 J. C. Bradford & Co.
General Partner 12/10/99 5,000 0.6250 J. C. Bradford & Co.
General Partner 12/14/99 15,000 0.6250 J. C. Bradford & Co.
TOTAL 521,300 917,031
======= =======
</TABLE>
<PAGE>
SCHEDULE 13D
- ------------------------------------ --------------------------------
| CUSIP No. 786444109000 | | Page 7 of 7 Pages |
| ------------------ | | ---- ----- |
- ------------------------------------ --------------------------------
No other person is known to have the right to receive or the power to
direct the receipt of dividends from, or any proceeds from the sale of, the
shares beneficially owned by The Burton Partnership, Limited Partnership and the
general partner.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect
- ------------------------------------------------------------------------------
to Securities of the Issuer
- ---------------------------
Except as described elsewhere herein, there are no contracts, arrangements,
understandings or relationships (legal or otherwise) among The Burton
Partnership, Limited Partnership and the general partner or between any such
person and any other person with respect to the securities, finder's fees, joint
ventures, loan or option arrangements, puts or calls, guarantees of profits,
division of profits or loss or the giving or withholding of proxies.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
December 13, 1999
--------------------------------------
Date
/s/ Donald W. Burton
---------------------------------------
Signature
Donald W. Burton/General Partner
---------------------------------------
Name/Title
